Previous Article | Next Article 
Journal of Clinical Microbiology, August 2004, p. 3805-3808, Vol. 42, No. 8
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.8.3805-3808.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Molecular Epidemiology of Enterobacteriaceae Isolates Producing Extended-Spectrum ß-Lactamases in a French Hospital
Jean-Philippe Lavigne,1,2 Nicole Bouziges,2 Catherine Chanal,3 Aba Mahamat,4 Sylvie Michaux-Charachon,1,2 and Albert Sotto1,5*
Laboratoire Universitaire d'Antibiologie, Faculté de Médecine, 30900 Nîmes,1
Laboratoire de Bactériologie, Virologie, et Parasitologie,2
Département d'Information Médicale,4
Service de Médecine Interne B, CHU de Nîmes, Groupe Hospitalo-Universitaire de Carémeau, 30029 Nîmes Cedex 9,5
Laboratoire de Bactériologie, Faculté de Médecine, 63001 Clermont Ferrand Cedex, France3
Received 18 December 2003/
Returned for modification 18 February 2004/
Accepted 14 May 2004

ABSTRACT
In 2002, 80 isolates of
Enterobacteriaceae producing extended-spectrum
ß-lactamases (ESBLs) were collected from infected
patients in our hospital.
Enterobacter aerogenes was the most
common bacterium isolated from all specimens (36.5%). The ESBLs
were predominantly (90%) TEM derivatives (TEM-24, TEM-3). Pulsed-field
gel electrophoresis highlighted that
E. aerogenes,
Klebsiella pneumoniae, and
Citrobacter koseri had a clonal propagation.

TEXT
Over the last 20 years, there has been an increased resistance
to ß-lactams because of the secretion of extended-spectrum
ß-lactamases (ESBLs) mediated by plasmids. This type
of resistance is now observed in all species of
Enterobacteriaceae and is currently disseminated throughout the world (
22,
29,
35). From 1991 to 1993, we described the first ESBL-producing
Enterobacteriaceae strains isolated in our hospital, a 1,588-bed
university hospital in southern France.
To evaluate the epidemiological evolution of Enterobacteriaceae producing ESBL in our hospital from 1993 onward, a prospective study was conducted from April 2002 to March 2003 (20). We screened 3,063 nonrepetitive clinical isolates of Enterobacteriaceae recovered consecutively from infection sites of hospital patients. Antibiotic susceptibility testing was performed on Muller-Hinton agar with antibiotic disks from Pasteur Diagnostics (Marne-la-Coquette, France), placed at defined points, with the Vitek 2 GNS-F7 card (bioMérieux, Marcy-l'Etoile, France). ESBL production was tested with the double-disk synergy test (31). Strains were studied whenever the synergy test was positive. Duplicates isolated from the same patient were excluded. Isolates from superficial wounds, those from stool, ear, nose, and throat specimens, and those not involved in infections as defined by the Centers for Disease Control and Prevention criteria were excluded (17).
The ß-lactamases were characterized by isoelectric focusing, performed with polyacrylamide gels as previously described. Standard enzymes (including TEM-1, TEM-3, TEM-24, SHV-5, and CTX-M-1) were used as pI markers (6). The ESBL that was neither a TEM nor an SHV derivative was identified by direct sequencing of the PCR product obtained with specific primers CTX-MF (5'-GCGATGTGCAGCACCAGTAA-3') and CTX-MR (5'-GGTTGAGGCTGGGTGAAGTA-3'), which were previously described (19). DNA sequencing of both strands of the PCR products was performed with an ABI 1377 automated sequencer with the ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction kit with AmpliTaq DNA polymerase FS (Perkin-Elmer/Applied Biosystems, Foster City, Calif.) at C. Chanal's laboratory.
The clonality of the strains was examined by pulsed-field gel electrophoresis (PFGE) with a CHEF DRII system (Bio-Rad SA, Ivry-sur-Seine, France) as previously described (20). The Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, and Citrobacter koseri chromosomal DNAs were digested overnight with the restriction enzyme XbaI (Promega, Madison, Wis.), whereas the Proteus mirabilis and Providencia stuartii DNAs were digested with SmaI (Promega). Electrophoresis was performed at 6 V/cm for 30 h; the pulse time ranged from 40 to 5 s for E. aerogenes, K. pneumoniae, C. koseri, and E. coli strains and from 25 to 5 s for P. mirabilis and P. stuartii. Because a single base mutation in the chromosomal DNA of an isolate is sufficient to introduce differences in three fragments of its restriction pattern, isolates with restriction patterns showing the same differences in one to three fragments were considered to belong to the same genotype (32). The PFGE patterns were analyzed with the GelCompar computer software for Windows, version 3.5 (Applied Maths, Kortrijk, Belgium), and compared by the algorithmic clustering method known as the unweighted pair group method using arithmetic averages with the Dice coefficient of similarity. Isolates were considered to be within a cluster if the coefficient of similarity was >80%.
Out of the 3,063 Enterobacteriaceae strains isolated, 80 produced an ESBL, i.e., 2.62%, in accordance with other French publications (1, 2, 11, 15), and corresponded to: E. aerogenes (n = 29 [36.3%]), K. pneumoniae (n = 15 [18.8%]), E. coli (n = 13 [16.2%]), C. koseri (n = 12 [15%]), P. mirabilis (n = 6 [7.5%]), P. stuartii (n = 4 [5%]), and K. oxytoca (n = 1 [1.2%]). No epidemic was reported during the surveillance period. The prevalence of the ESBL production in the various species was 20.34% (12 of 59) for C. koseri, 17.9% (29 of 162) for E. aerogenes, 8.24% (15 of 182) for K. pneumoniae, 7.55% (4 of 53) for P. stuartii, 2.33% (6 of 258) for P. mirabilis, 1.22% (1 of 82) for K. oxytoca, and 0.71% (13 of 1,827) for E. coli. These results were close to those found in other French hospitals, except for E. aerogenes (17.9% in our hospital compared to high levels ranging from 31.9 to 53.5% in other hospitals) (5, 11, 25). The majority of strains were isolated from urinary specimens (n = 51 [63.8%]) (Table 1). Out of the 80 ESBL-producing strains isolated, 11.25% were found in the recovery unit, 20% were found in the intensive care unit (ICU), 20% were found in the geriatric unit, and 36.25% were found in the medicine unit (Table 1). However, among the Enterobacteriaceae strains isolated in each unit, the proportion of ESBL-producing strains was 7.3% (9 of 123) in the geriatric unit and 6.75% (16 of 237) in the recovery unit. This rate was only 1.8% in the medicine unit (29 of 1,596). Indeed, 32 (41.6%) out of 77 patients had stayed in an ICU in the 6 months prior to isolation of the ESBL-producing bacteria. The propagation of the ESBL-producing strain could be correlated to time spent in an ICU, as already described by others (12, 36). Contrary to previous studies, ESBL strains were not detected in pediatric patients (21, 28). E. aerogenes was the predominant bacterium, and this has been the trend in France since 1993, while ESBL-producing K. pneumoniae isolates are decreasing (3, 5, 20). This phenomenon has also been observed in other countries such as the United States and Spain, although not in Italy (10, 29, 30). Furthermore, we isolated few strains of K. pneumoniae in geriatric wards (13.3%, 2 out of 15), where the first ESBL-producing Enterobacteriaceae strains were described in our hospital (20).
View this table:
[in this window]
[in a new window]
|
TABLE 1. Characteristics of ESBL-producing Enterobacteriaceae strains isolated in a French university hospital in 2002
|
The following five different ESBLs were characterized: TEM-24
(
n = 38 [47.5%]), TEM-3 (
n = 34 [42.5%]), CTX-M-15 (
n = 4 [5%]),
and CTX-M-3 and CTX-M-14 (
n = 2 [2.5%] each) (Table
1).
E. aerogenes and
P. stuartii secreted exclusively TEM-24, and
P. mirabilis,
C. koseri, and
K. oxytoca, secreted exclusively TEM-3.
K. pneumoniae mainly produced TEM-3 (
n = 14, [93.3%]). Lastly,
E. coli produced
the greatest range of ESBLs, especially the CTX-M type. Since
1988, members of the family
Enterobacteriaceae producing TEM-24,
particularly
E. aerogenes, have spread massively throughout
several European countries such as France, Belgium, Italy, and
Spain (
7,
9,
13,
14,
16,
18,
23,
25,
27). TEM-24 has been found
in other strains that produced ESBL (
E. coli and
P. stuartii)
and confirmed plasmidic diffusion of this ß-lactamase,
without providing evidence of epidemic outbreaks. However, the
production of TEM-24 in
K. pneumoniae only concerned 13.3% of
the
K. pneumoniae isolates producing ESBLs, while in a neighboring
geographic region these bacteria remained at epidemic proportions
(
18). In France, TEM-3 is secreted largely by
Klebsiella spp.,
P. mirabilis, and
C. koseri, while in other countries, other
ESBLs are in the majority (
4,
8,
11,
24,
26,
30,
34). ESBLs
in the CTX-M group (CTX-M-3, CTX-M-14, and CTX-M-15) were only
observed in
E. coli strains. The majority of these enzymes have
been found in South America, Australia, Japan, South Africa,
Israel, and Eastern Europe, while a recent study confirmed their
absence in the United States (
11,
26,
33). It could therefore
be concluded that these enzymes are responsible for an increased
role in resistance mechanisms especially for
E. coli.
In our study, PFGE analysis showed that E. aerogenes, K. pneumoniae, and C. koseri had a clonal propagation. All of the results are summarized in Table 1. Eight clusters, each containing isolates with coefficients of similarity of more than 80%, were identified among E. aerogenes isolates. An example of patterns obtained with XbaI are shown in Fig. 1. Four clusters were identified among K. pneumoniae isolates. However, a high level of genetic heterogeneity was found in two isolates. Thus, five clusters were identified among C. koseri strains.
Ten years after our principal study, six new varieties of
Enterobacteriaceae were identified as producing ESBLs. We noted a complex evolution:
the persistence of TEM-3 as the major ESBL secreted by
K. pneumoniae,
dissemination of clonal strains of
E. aerogenes producing TEM-24,
diffusion of these resistance mechanisms to other microorganisms
such as
E. coli and
P. stuartii, isolation of
E. coli producing
CTX-M, and dissemination of ESBL-producing strains throughout
the hospital. This type of propagation in the hospital environment
is rapid and alarming, despite the introduction of procedures
aimed at limiting patient-to-patient diffusion of multiresistant
bacteria, as well as a concerted policy regarding the use of
extended-spectrum ß-lactams (
1,
5,
11). These surveillance
measures, combined with effective screening, should assist in
the fight against the worrying propagation of these microorganisms.

FOOTNOTES
* Corresponding author. Mailing address: Laboratoire Universitaire d'Antibiologie, Faculté de Médecine, Ave. Kennedy, 30900 Nîmes, France. Phone: (33) 4 66 68 32 31. Fax: (33) 4 66 68 38 24. E-mail:
albert.sotto{at}chu-nimes.fr.


REFERENCES
1 - Albertini, M. T., C. Benoit, L. Berardi, Y. Berrouane, A. Boisivon, P. Cahen, C. Cattoen, Y. Costa, P. Darchis, E. Deliere, D. Demontrond, F. Eb, F. Golliot, G. Grise, A. Harel, J. L. Koeck, M. P. Lepennec, C. Malbrunot, M. Marcollin, S. Maugat, M. Nouvellon, B. Pangon, S. Ricouart, M. Roussel-Delvallez, A. Vachee, A. Carbonne, L. Marty, V. Jarlier, and the Microbiology Surveillance Network of Northern France. 2002. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in northern France: a five-year multicentre incidence study. J. Hosp. Infect. 52:107-113.[CrossRef][Medline]
2 - Arpin, C., V. Dubois, L. Coulange, C. Andre, I. Fischer, P. Noury, F. Grobost, J. P. Brochet, J. Jullin, B. Dutilh, G. Larribet, I. Lagrange, and C. Quentin. 2003. Extended-spectrum ß-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob. Agents Chemother. 47:3506-3514.[Abstract/Free Full Text]
3 - Arpin, C., C. Coze, A. M. Rogues, J. P. Gachie, C. Bebear, and C. Quentin. 1996. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J. Clin. Microbiol. 34:2163-2169.[Abstract]
4 - Barroso, H., A. Freitas-Vieira, L. M. Lito, J. M. Cristino, M. J. Salgado, H. F. Neto, J. C. Sousa, G. Soveral, T. Moura, and A. Duarte. 2000. Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme. J. Antimicrob. Chemother. 45:611-616.[Abstract/Free Full Text]
5 - Bertrand, X., D. Hocquet, K. Boisson, E. Siebor, P. Plesiat, and D. Talon. 2003. Molecular epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in a French university-affiliated hospital. Int. J. Antimicrob. Agents 22:128-133.[CrossRef][Medline]
6 - Bonnet, R., J. L. M. Sampaio, C. Chanal, D. Sirot, C. De Champs, J. L. Viallard, R. Labia, and J. Sirot. 2000. A novel class A extended-spectrum ß-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob. Agents Chemother. 44:3061-3068.[Abstract/Free Full Text]
7 - Bosi, C., A. Davin-Regli, C. Bornet, M. Mallea, J. M. Pages, and C. Bollet. 1999. Most Enterobacter aerogenes strains in France belong to a prevalent clone. J. Clin. Microbiol. 37:2165-2169.[Abstract/Free Full Text]
8 - Bradford, P. A., C. E. Cherubin, V. Idemyor, B. A. Rasmussen, and K. Bush. 1994. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing ß-lactamases in a single isolate. Antimicrob. Agents Chemother. 38:761-766.[Abstract/Free Full Text]
9 - Canton, R., A. Oliver, T. M. Coque, M. C. Varela, J. C. Perez-Diaz, and F. Baquero. 2002. Epidemiology of extended-spectrum ß-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J. Clin. Microbiol. 40:1237-1243.[Abstract/Free Full Text]
10 - Coque, T. M., A. Oliver, J. C. Perez-Diaz, F. Baquero, and R. Canton. 2002. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum ß-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob. Agents Chemother. 46:500-510.[Abstract/Free Full Text]
11 - De Champs, C., D. Sirot, C. Chanal, R. Bonnet, and J. Sirot. 2000. A 1998 survey of extended-spectrum ß-lactamases in Enterobacteriaceae in France. Antimicrob. Agents Chemother. 44:3177-3179.[Abstract/Free Full Text]
12 - Decre, D., B. Gachot, J. C. Lucet, G. Arlet, E. Bergogne-Berezin, and B. Regnier. 1998. Clinical and bacteriologic epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin. Infect. Dis. 27:834-844.[Medline]
13 - De Gheldre, Y., M. J. Struelens, Y. Glupczynski, P. De Mol, N. Maes, C. Nonhoff, H. Chetoui, C. Sion, O. Ronveaux, M. Vaneechoutte, and Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières (GDEPIH-GOSPIZ). 2001. National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J. Clin. Microbiol. 39:889-896.[Abstract/Free Full Text]
14 - Dumarche, P., C. De Champs, D. Sirot, C. Chanal, R. Bonnet, and J. Sirot. 2002. TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob. Agents Chemother. 46:1128-1131.[Abstract/Free Full Text]
15 - Eveillard, M., M. Biendo, B. Canarelli, F. Daoudi, G. Laurans, F. Rousseau, and D. Thomas. 2001. Spread of Enterobacteriaceae producing broad-spectrum beta-lactamase and the development of their incidence over a 16-month period in a university hospital center. Pathol. Biol. 49:515-521.[Medline]
16 - Galdbart, J. O., F. Lemann, D. Ainouz, P. Feron, N. Lambert-Zechovsky, and C. Branger. 2000. TEM-24 extended-spectrum beta-lactamase-producing Enterobacter aerogenes: long-term clonal dissemination in French hospitals. Clin. Microbiol. Infect. 6:316-323.[CrossRef][Medline]
17 - Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-139.[CrossRef][Medline]
18 - Giraud-Morin, C., and T. Fosse. 2003. A seven-year survey of Klebsiella pneumoniae producing TEM-24 extended-spectrum beta-lactamase in Nice University Hospital (1994-2000). J. Hosp. Infect. 54:25-31.[CrossRef][Medline]
19 - Gniadkowski, M., I. Schneider, A. Palucha, R. Jungwirth, B. Mikiewicz, and A. Bauernfeind. 1998. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing ß-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 42:827-832.[Abstract/Free Full Text]
20 - Gouby, A., C. Neuwirth, G. Bourg, N. Bouziges, M. J. Carles-Nurit, E. Despaux, and M. Ramuz. 1994. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum ß-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J. Clin. Microbiol. 32:301-305.[Abstract/Free Full Text]
21 - Hammami, A., G. Arlet, S. Ben Redjeb, F. Grimont, A. Ben Hassen, A. Rekik, and A. Philippon. 1991. Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur. J. Clin. Microbiol. Infect. Dis. 10:641-646.[CrossRef][Medline]
22 - Jacoby, G. A. 1997. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect. Dis. Clin. N. Am. 11:875-887.[CrossRef][Medline]
23 - Jalaluddin, S., J. M. Devaster, R. Scheen, M. Gerard, and J. P. Butzler. 1998. Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J. Clin. Microbiol. 36:1846-1852.[Abstract/Free Full Text]
24 - Liu, P. Y., J. C. Tung, S. C. Ke, and S. L. Chen. 1998. Molecular epidemiology of extended-spectrum ß-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan. J. Clin. Microbiol. 36:2759-2762.[Abstract/Free Full Text]
25 - Mammeri, H., G. Laurans, M. Eveillard, S. Castelain, and F. Eb. 2001. Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J. Clin. Microbiol. 39:2184-2190.[Abstract/Free Full Text]
26 - Paterson, D. L., K. M. Hujer, A. M. Hujer, B. Yeiser, M. D. Bonomo, L. B. Rice, R. A. Bonomo, and the International Klebsiella Study Group. 2003. Extended-spectrum ß-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type ß-lactamases. Antimicrob. Agents Chemother. 47:3554-3560.[Abstract/Free Full Text]
27 - Perilli, M., E. Dell'Amico, B. Segatore, M. R. de Massis, C. Bianchi, F. Luzzaro, G. M. Rossolini, A. Toniolo, G. Nicoletti, and G. Amicosante. 2002. Molecular characterization of extended-spectrum ß-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40:611-614.[Abstract/Free Full Text]
28 - Poilane, I., P. Cruaud, E. Lachassinne, F. Grimont, P. A. Grimont, M. Collin, J. Gaudelus, J. C. Torlotin, and A. Collignon. 1993. Enterobacter cloacae cross-colonization in neonates demonstrated by ribotyping. Eur. J. Clin. Microbiol. Infect. Dis. 12:820-826.[CrossRef][Medline]
29 - Rice, L. B., S. H. Willey, G. A. Papanicolaou, A. A. Medeiros, G. M. Eliopoulos, R. C. Moellering, Jr., and G. A. Jacoby. 1990. Outbreak of ceftazidime resistance caused by extended-spectrum ß-lactamases at a Massachusetts chronic-care facility. Antimicrob. Agents Chemother. 34:2193-2199.[Abstract/Free Full Text]
30 - Sanguinetti, M., B. Posteraro, T. Spanu, D. Ciccaglione, L. Romano, B. Fiori, G. Nicoletti, S. Zanetti, and G. Fadda. 2003. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum ß-lactamase detection method. J. Clin. Microbiol. 41:1463-1468.[Abstract/Free Full Text]
31 - Sirot, J. 1996. Detection of extended-spectrum plasmid-mediated beta-lactamases by disk diffusion. Clin. Microbiol. Infect. 2(Suppl. 1):S35-S39.
32 - Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]
33 - Tenover, F. C., P. M. Raney, P. P. Williams, J. K. Rasheed, J. W. Biddle, A. Oliver, S. K. Fridkin, L. Jevitt, and J. E. McGowan, Jr. 2003. Evaluation of the NCCLS extended-spectrum ß-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE. J. Clin. Microbiol. 41:3142-3146.[Abstract/Free Full Text]
34 - Urban, C., K. S. Meyer, N. Mariano, J. J. Rahal, R. Flamm, B. A. Rasmussen, and K. Bush. 1994. Identification of TEM-26 ß-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother. 38:392-395.[Abstract/Free Full Text]
35 - Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 15:S94-S103.
36 - Yuan, M., H. Aucken, L. M. Hall, T. L. Pitt, and D. M. Livermore. 1998. Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J. Antimicrob. Chemother. 41:527-539.[Abstract/Free Full Text]
Journal of Clinical Microbiology, August 2004, p. 3805-3808, Vol. 42, No. 8
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.8.3805-3808.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Arpin, C., Quentin, C., Grobost, F., Cambau, E., Robert, J., Dubois, V., Coulange, L., Andre, C., on behalf of the Scientific Committee of ONERBA,
(2009). Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother
63: 1205-1214
[Abstract]
[Full Text]
-
Tran, Q.-T., Dupont, M., Lavigne, J.-P., Chevalier, J., Pages, J.-M., Sotto, A., Davin-Regli, A.
(2009). Occurrence of Efflux Mechanism and Cephalosporinase Variant in a Population of Enterobacter aerogenes and Klebsiella pneumoniae Isolates Producing Extended-Spectrum {beta}-Lactamases. Antimicrob. Agents Chemother.
53: 1652-1656
[Abstract]
[Full Text]
-
Barlow, M., Fatollahi, J., Salverda, M.
(2009). Evidence for recombination among the alleles encoding TEM and SHV {beta}-lactamases. J Antimicrob Chemother
63: 256-259
[Abstract]
[Full Text]
-
Mroczkowska, J. E., Barlow, M.
(2008). Recombination and Selection Can Remove blaTEM Alleles from Bacterial Populations. Antimicrob. Agents Chemother.
52: 3408-3410
[Abstract]
[Full Text]
-
Mroczkowska, J. E., Barlow, M.
(2008). Fitness Trade-Offs in blaTEM Evolution. Antimicrob. Agents Chemother.
52: 2340-2345
[Abstract]
[Full Text]
-
Galas, M., Decousser, J.-W., Breton, N., Godard, T., Allouch, P. Y., Pina, P., and the College de Bacteriologie Virologie Hygiene,
(2008). Nationwide Study of the Prevalence, Characteristics, and Molecular Epidemiology of Extended-Spectrum-{beta}-Lactamase-Producing Enterobacteriaceae in France. Antimicrob. Agents Chemother.
52: 786-789
[Abstract]
[Full Text]
-
Brasme, L., Nordmann, P., Fidel, F., Lartigue, M. F., Bajolet, O., Poirel, L., Forte, D., Vernet-Garnier, V., Madoux, J., Reveil, J. C., Alba-Sauviat, C., Baudinat, I., Bineau, P., Bouquigny-Saison, C., Eloy, C., Lafaurie, C., Simeon, D., Verquin, J. P., Noel, F., Strady, C., De Champs, C.
(2007). Incidence of class A extended-spectrum {beta}-lactamases in Champagne-Ardenne (France): a 1 year prospective study. J Antimicrob Chemother
60: 956-964
[Abstract]
[Full Text]
-
Arpin, C., Coulange, L., Dubois, V., Andre, C., Fischer, I., Fourmaux, S., Grobost, F., Jullin, J., Dutilh, B., Couture, J.-F., Noury, P., Lagrange, I., Ducastaing, A., Doermann, H.-P., Quentin, C.
(2007). Extended-Spectrum-{beta}-Lactamase-Producing Enterobacteriaceae Strains in Various Types of Private Health Care Centers. Antimicrob. Agents Chemother.
51: 3440-3444
[Abstract]
[Full Text]
-
Dupont, M., James, C. E., Chevalier, J., Pages, J.-M.
(2007). An Early Response to Environmental Stress Involves Regulation of OmpX and OmpF, Two Enterobacterial Outer Membrane Pore-Forming Proteins. Antimicrob. Agents Chemother.
51: 3190-3198
[Abstract]
[Full Text]
-
Manzur, A., Tubau, F., Pujol, M., Calatayud, L., Dominguez, M. A., Pena, C., Sora, M., Gudiol, F., Ariza, J.
(2007). Nosocomial Outbreak Due to Extended-Spectrum-Beta-Lactamase- Producing Enterobacter cloacae in a Cardiothoracic Intensive Care Unit. J. Clin. Microbiol.
45: 2365-2369
[Abstract]
[Full Text]
-
Lavigne, J.-P., Marchandin, H., Delmas, J., Moreau, J., Bouziges, N., Lecaillon, E., Cavalie, L., Jean-Pierre, H., Bonnet, R., Sotto, A.
(2007). CTX-M {beta}-Lactamase-Producing Escherichia coli in French Hospitals: Prevalence, Molecular Epidemiology, and Risk Factors. J. Clin. Microbiol.
45: 620-626
[Abstract]
[Full Text]
-
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., Poirel, L., Woodford, N.
(2007). CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother
59: 165-174
[Abstract]
[Full Text]
-
Lavigne, J.-P., Marchandin, H., Delmas, J., Bouziges, N., Lecaillon, E., Cavalie, L., Jean-Pierre, H., Bonnet, R., Sotto, A.
(2006). qnrA in CTX-M-Producing Escherichia coli Isolates from France. Antimicrob. Agents Chemother.
50: 4224-4228
[Abstract]
[Full Text]
-
Thiolas, A., Bollet, C., La Scola, B., Raoult, D., Pages, J.-M.
(2005). Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient. Antimicrob. Agents Chemother.
49: 1354-1358
[Abstract]
[Full Text]